Neuspera Medical

Focus: Neuspera Medical develops implantable sacral neuromodulation systems for urinary dysfunction, operating as a Series C+ medical device company headquartered in San Jose, CA.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

SERIES C +

Open Jobs

About Neuspera Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Neuspera Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

5 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Neuspera Implantable Sacral Neuromodulation System

Urinary Urge Incontinence

N/A

Clinical Trials (1)

NCT07247136Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System

N/A

Help build intelligence for Neuspera Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused portfolio in high-unmet-need neurostimulation space with multiple pipeline programs targeting urinary incontinence and overactive bladder
Series C+ funding stage suggests sufficient capital runway with potential for Series D or exit within 3-5 years
Early-stage pipeline (1 Phase 1 program) offers opportunity to shape clinical strategy and regulatory pathway from ground up

Watch Out For

Zero currently active job openings indicates potential hiring freeze, flat organizational growth, or recent restructuring
Minimal public disclosure (no published data, no recent news, no financials available) raises transparency concerns about company momentum and internal health
Pre-revenue or early-revenue stage with no marketed products creates cash burn risk and longer timeline to profitability

Generated by Claude from Neuspera Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Neuspera Implantable Sacral Neuromodulation System

Urinary Urgency Incontinence

N/A

Clinical Trials (1)

NCT07144813Post-Approval Study of the Neuspera Sacral Neuromodulation System

N/A

Neuspera Implantable Sacral Nerve Stimulation System

Urinary Urgency Incontinence

N/A

Clinical Trials (1)

NCT04232696Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)

N/A

Neuspera Implantable Sacral Neuromodulation System

Urinary Urge Incontinence

N/A

Clinical Trials (1)

NCT07383688FREEDOM Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics

N/A

AHLeveeS System

Overactive Bladder

Phase 1

Clinical Trials (1)

NCT03643380Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 5 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo